Parkinson Society British Columbia is proud to connect our community with the resources and tools they need to live well. Since Parkinson's disease (PD) can present differently in each individual, the Society endeavours to maintain impartiality when providing...
News
NEW! Clinical Guidelines for Parkinson’s Disease (2nd Edition)
Sep 19, 2019 | News
The first edition of the Canadian Guidelines on Parkinson’s Disease was published in 2012. The second edition, providing updates with input from healthcare professionals, people with Parkinson's, and Parkinson Canada, was released in September 2019. The...
Parkinson Society BC Information Kiosk at Pacific Parkinson’s Research Centre
Aug 22, 2019 | News
In an effort to further expand our reach, Parkinson Society BC is pleased to announce a new collaboration with the Pacific Parkinson's Research Centre (PPRC). Beginning Thursday, October 3, 2019, we will be offering information and consultations to those...
Deadline extended for Moving Forward, Together Scholarships
Aug 22, 2019 | News
To maximize the benefit of the Provincial Conference Moving Forward, Together to British Columbia's Parkinson's community, Parkinson Society British Columbia (PSBC) is offering a limited number of scholarships for people with Parkinson's (PWP) and family...
Join the SuperWalk Donor Dash to win a two-night getaway!
Jun 13, 2019 | News
This September, thousands of participants across the country will gather together for Parkinson SuperWalk. This event is meant to empower the Parkinson's community and celebrate its resilience. No matter what the challenges, together we can make a difference....
SURVEY: MAO-B Inhibitor Use
Jun 3, 2019 | News
If you've used Rasagiline (Azilect) or Selegline, we want your feedback. Safinamide (brand name Onstryv), which was approved in Europe in February 2015 and in the United States in March 2017, is indicated as an add-on therapy to a regimen that includes levodopa for...
Survey Summary: Sinemet vs. Generic Drug Usage
May 23, 2019 | News
Parkinson Society BC (PSBC) recently conducted a survey with the intent of better understanding the patient’s perspective in achieving symptom control with brand name (Sinemet) vs. generic forms of levodopa. The following is a summary of the 521 responses received:...
Parkinson’s Community Needs Survey: Your feedback requested
May 7, 2019 | News
We are currently conducting a survey of those affected by Parkinson's disease (PD) in BC. The feedback from this anonymous survey will serve as a guide for us in determining priorities for the future of our programs, services, and advocacy efforts. We appreciate...
SURVEY: Sinemet vs. Generic Levodopa Drug Usage
Apr 24, 2019 | News
As you may know from our recent announcement, Sinemet CR (Controlled Release) is being discontinued by the manufacturer and some dosages of Sinemet IR (Immediate Release or Regular) are in short supply. While it is our understanding that the majority of people are...